We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound in patients with refractory solid tumors.
- Authors
Simon, George R; Ilaria, Robert L, Jr; Sovak, Mika A; Williams, Charles C; Haura, Eric B; Cleverly, Ann L; Sykes, Amanda K; Wagner, Margaret M; de Alwis, Dinesh P; Slapak, Christopher A; Miller, Mary A; Spriggs, David R
- Abstract
This phase I study was carried out to determine the phase II recommended dose of tasisulam sodium (hereafter, tasisulam), a novel anticancer agent with a unique mechanism of action.
- Publication
Cancer chemotherapy and pharmacology, 2011, Vol 68, Issue 5, p1233
- ISSN
1432-0843
- Publication type
Journal Article
- DOI
10.1007/s00280-011-1593-0